Vanguard Group Inc Biocept Inc Transaction History

Vanguard Group Inc

  • $5.46 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
BUY
$0.47 - $0.89 $175 - $332
374 Added 0.06%
617,984 $327,000
Q3 2022

Nov 14, 2022
SELL
$0.75 - $1.2 $28,548 - $45,676
-38,064 Reduced 5.81%
617,610 $569,000
Q4 2021

Feb 14, 2022
SELL
$3.43 - $4.22 $9,988 - $12,288
-2,912 Reduced 0.44%
655,674 $2.37 Million
Q2 2021

Aug 13, 2021
BUY
$4.03 - $5.07 $2.65 Million - $3.34 Million
658,586 New
658,586 $2.76 Million

About BIOCEPT INC

BIOC Quotes by TradingView
  • Ticker BIOC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 16,922,900
  • Market Cap $1.18M
  • Description
  • Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for ...
More about BIOC
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email